Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

被引：4
|
作者：
Scagliotti, Giorgio
Kaiser, Christopher
Biesma, Bonne
Manegold, Christian
Gatzemeier, Ulrich
Serwatowski, Piotr
Syrigos, Kostas
Balint, Beatrix
Smit, Hans J.
Vansteenkiste, Johan
机构：
[1] Univ Turin, S Luigi Hosp, Orbassano, Italy
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Jeroen Bosch Ziekenhuis, sHertogenbosch, Netherlands
[4] Univ Heidelberg, Med Ctr, D-6800 Mannheim, Germany
[5] Hosp Grosshansdorf, Grosshansdorf, Germany
[6] Specjalistyczny Szpital, Szczecin, Poland
[7] Athens Med Sch, Athens, Greece
[8] Cty Councils Hop Chest Dis, Deszk, Hungary
[9] Ziekenhuis Rijnstate, Arnhem, Netherlands
[10] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
10.1097/01.JTO.0000283223.48520.7c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S375 / S375
页数：1
相关论文
共 50 条
  • [1] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    [J]. EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [2] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
  • [3] A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer
    Goksel, T
    Hatipoglu, ON
    Ozturk, C
    Gorguner, M
    Kiyik, M
    Yilmaz, U
    Guzelant, A
    Tasbakan, S
    Tabakoglu, E
    Firat, H
    Tutar, U
    Cikrikicioglu, S
    Akkoclu, A
    Soyer, S
    Cakir, E
    Itil, O
    Sanal, S
    [J]. RESPIROLOGY, 2005, 10 (04) : 456 - 463
  • [4] Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
    Sandler, AB
    Nemunaitis, J
    Denham, C
    von Pawel, J
    Cormier, Y
    Gatzemeier, U
    Mattson, K
    Manegold, C
    Palmer, MC
    Gregor, A
    Nguyen, B
    Niyikiza, C
    Einhorn, LH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 122 - 130
  • [5] Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
    Scagliotti, Giorgio V.
    Park, Keunchil
    Patil, Shekar
    Rolski, Janusz
    Goksel, Tuncay
    Martins, Renato
    Gans, Steven J. M.
    Visseren-Grul, Carla
    Peterson, Patrick
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) : 2298 - 2303
  • [6] Safety and Resource Utilization by Non-small Cell Lung Cancer Histology Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaive Patients with Advanced Non-small Cell Lung Cancer
    Novello, Silvia
    Pimentel, Francisco Luis
    Douillard, Jean-Yves
    O'Brien, Mary
    von Pawel, Joachim
    Eckardt, John
    Liepa, Astra M.
    Simms, Lorinda
    Visseren-Grul, Carla
    Paz-Ares, Luis
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1602 - 1608
  • [7] Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non-Small Cell Lung Cancer
    Dickgreber, Nicolas J.
    Fink, Thomas H.
    Latz, Jane E.
    Hossain, Anwar M.
    Musib, Luna C.
    Thomas, Michael
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (01) : 382 - 389
  • [8] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    [J]. Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [9] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [10] Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
    Zhang, Guan-Zhong
    Jiao, Shun-Chang
    Meng, Zhao-Ting
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
12345